Moreover, the animal model shares more biological markers that are similar to other human cancers, such as activation of EGFR and increased levels of p-Stat3 and pro-inflammation cytokines, which could provide more strategies for exploring anal cancer treatments [16]. This evidence concerns the gene EGFR and anal carcinoma.